CoChat

High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury

Open access
Moens, An L., Champion, Hunter C., Claeys, Marc J., Tavazzi, Barbara, Kaminski, Pawel M., Wolin, Michael S., Borgonjon, Dirk J., Van Nassauw, Luc, Haile, Azeb, Zviman, Muz, Bedja, Djahida, Wuyts, Floris L., Elsaesser, Rebecca S., Cos, Paul, Gabrielson, Kathy L., Lazzarino, Giuseppe, Paolocci, Nazareno, Timmermans, Jean-Pierre, Vrints, Christiaan J., Kass, David A. · 2008 · Circulation
Cited by 119

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background— The B vitamin folic acid (FA) is important to mitochondrial protein and nucleic acid synthesis, is an antioxidant, and enhances nitric oxide synthase activity. Here, we tested whether FA reduces myocardial ischemic dysfunction and postreperfusion injury. Methods and Results— Wistar rats were pretreated with either FA (10 mg/d) or placebo for 1 week and then underwent in vivo transient left coronary artery occlusion for 30 minutes with or without 90 minutes of reperfusion (total n=131; subgroups used for various analyses). FA (4.5×10 −6 mol/L IC) pretreatment and global ischemia/reperfusion (30 minutes/30 minutes) also were performed in vitro (n=28). After 30 minutes of ischemia, global function declined more in controls than in FA-pretreated rats (ΔdP/dtmax, −878±586 versus −1956±351 mm Hg/s placebo; P =0.03), and regional thickening was better preserved (37.3±5.3% versus 5.1±0.6% placebo; P =0.004). Anterior wall perfusion fell similarly (−78.4±9.3% versus −71.2±13.8% placebo at 30 minutes), yet myocardial high-energy phosphates ATP and ADP reduced by ischemia in controls were better preserved by FA pretreatment (ATP: control, 2740±58 nmol/g; ischemia, 947±55 nmol/g; ischemia plus FA, 1332±101 nmol/g; P =0.02). Basal oxypurines (xanthine, hypoxanthine, and urate) rose with FA pretreatment but increased less during ischemia than in controls. Ischemic superoxide generation declined (3124±280 cpm/mg FA versus 5898±474 cpm/mg placebo; P =0.001). After reperfusion, FA-treated hearts had smaller infarcts (3.8±1.2% versus 60.3±4.1% placebo area at risk; P <0.002) and less contraction band necrosis, terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling positivity, superoxide, and nitric oxide synthase uncoupling. Infarct size declined similarly with 1 mg/d FA. Conclusions— FA pretreatment blunts myocardial dysfunction during ischemia and ameliorates postreperfusion injury. This is coupled to preservation of high-energy phosphates, reducing subsequent reactive oxygen species generation, eNOS-uncoupling, and postreperfusion cell death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.107.725481

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 119

Metadata

Authors
Moens, A. L., Champion, H. C., Claeys, M. J., Tavazzi, B., Kaminski, P. M., Wolin, M. S., Borgonjon, D. J., Van Nassauw, L., Haile, A., Zviman, M., Bedja, D., Wuyts, F. L., Elsaesser, R. S., Cos, P., Gabrielson, K. L., Lazzarino, G., Paolocci, N., Timmermans, J.-P., Vrints, C. J., & Kass, D. A.
Venue
Circulation
Published
2008-04-08
Volume
117
Issue
14
Pages
1810-1819
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2002629623
Cited by
119
References
7
FWCI
8.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.